chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her hand was heavy; not comfortable; She experienced injection site pain the same as flu shot; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (her hand was heavy), MALAISE (not comfortable) and VACCINATION SITE PAIN (She experienced injection site pain the same as flu shot) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Cholesterol.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced LIMB DISCOMFORT (her hand was heavy), MALAISE (not comfortable) and VACCINATION SITE PAIN (She experienced injection site pain the same as flu shot). The patient was treated with IBUPROFEN at a dose of 200 milligram. On 21-Feb-2021, LIMB DISCOMFORT (her hand was heavy), MALAISE (not comfortable) and VACCINATION SITE PAIN (She experienced injection site pain the same as flu shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included asthma and cholesterol medications.   This case was linked to MOD-2021-047975 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: TCR received and the reporter denied further follow up.; Sender's Comments:  MOD-2021-047975:
Symptoms began on 11/2/00, after awakening in the morning with a temperature of 103F, vomiting X 4, headache and chills. Temperature was 99F-101F on 11/3/00 with 14cm X 16cm diameter indurated right area of left deltoid with redness to inner arm and tender to touch.
Headache, Myalgia, soreness & swelling at injection site, diaphoretic, fatigue Narrative:
Arm sore, swollen, painful at injection site on Tuesday (following day), began running temperature late Tuesday night and all day Wednesday (101.3 was highest), returned to work on Thursday.  About 1:25, started feeling lightheaded and recognized an SVT event coming on.  Coworkers called School Clinic personnel and ambulance.  BP was 70/40.  Approximately 30  minutes later, I began to rebound and I refused ambulance transport to the hospital and let my husband take me.   When I arrived at the ER at 2:30, my BP was 118/59.
Seven days following the immunization my arm began to itch and burn forming a 7cm x 5cm area of induration.  This well demarcated area was maroon in color with bruising at 1 o'clock.  I applied ice to the area, elevated my arm and took Tylenol 1000mg every 6-8 hours.  The visible inflammation has subsided after 60 hours (2.5 days).  My arm continues to burn and itch but is no longer indurated, or maroon.  I am continuing to have dull headaches, beginning 5 days after immunization.  No fever.
have been exposed with tested positive lady; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation .  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced have been exposed with tested positive lady. The patient had not got second shot yet. The outcome of event was unknown.    Information on the Batch/Lot number has been requested.
A report was received from a health care professional on 11/04/03, concerning a male vaccinee of unknown age who received 2 doses of Fluvirin, the first on 10/23/03 and the second on 11/04/03. On 10/23/03, the vaccinee received 035ml Fluvirin. Subsequently on 11/04/03 the vaccinee was inadvertently administered 0.5ml Fluvirin instead of the pneumococcal vaccine. The vaccinee had not exhibited any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/10/03: Follow up information received from a health care professional on 12/10/03 indicated that the reporter had followed up with the patient on 12/02/03 and the patient was feeling well and had no adverse events. No follow up pending.
Pain in left armpit (lymphnodes)- 4 days Back muscle pains - 24 hours
Both arms broke out with a rash of little fine bumps; This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 27Feb2021 at 02:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Mar2021 at 00:00, the patient's both arms broke out with a rash of little fine bumps. The patient did not receive any treatment for the event both arms broke out with a rash of little fine bumps. The clinical outcome of the event both arms broke out with a rash of fine bumps was not resolved at the time of the report.   Information about lot/batch number cannot be obtained. No further information is expected.
None. HIB given instead of Meningococcal vaccine. Pt family notified and will return another day for correct vaccine.
Pt states following shot he experienced pain in knees, elbows, L/ankle, and L/shoulder. Pt states he was in PT for three weeks.After 4th dose, pt experienced arm weakening and difficulty lifting objects,loss of sleep,anxiety and tiredness.
No additional AE reported; Customer reporting administration of improperly stored PEDVAX HIB and ROTATEQ; This spontaneous report was received from an office manager, concerning 10-week-old female patient. The patient's concurrent condition, concomitant medications and drug allergies were not reported, she presented for a physical examination without any concerns (well child visit) at the time of vaccination.   On 07-APR-2021, the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally at the dose of 2 milliliter (ml), lot number 1687012 has been verified to be a valid lot number, expiration date reported and validated as 08-JUL-2021 (strength was not provided) and with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), at the dose of 0.5ml, intramuscular, lot # T001206 has been verified to be a valid lot number with an expiration date reported and validated as 03-JUN-2022 (anatomical location was not provided), both vaccines for prophylaxis (product storage error), however, the temperature was not reported.   It was stated that the patient did not received any treatment, it was confirmed that the operator was trained, and it was used according to the instruction leaflet. Previous temperature excursions were reported as yes, and digital data logger was involved. No adverse events were reported, nor product quality complain.   The reporter considered product storage error to be not related to haemophilus b Conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) because it was attributable to other factors (not specified).  This is one of the several reports received from the same source.; Sender's Comments:  US-009507513-2105USA001739: US-009507513-2106USA001370: US-009507513-2106USA001659:
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 24-year-old female patient (not pregnant) received the 2nd dose of BNT162B2 (Comirnaty, batch/lot# unknown), on Aug 19, 2021, at the age of 24, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Comirnaty), for COVID-19 immunization. The patient experienced palpitations/heart started racing, and chest pain/chest was in pain, onset Aug 20, 2021, with outcome of unknown. Heart started racing and chest was in pain were evaluated at a physician office visit. Additional Information: The patient stated "24 hours after the 2nd dose, my heart started racing and chest was in pain. This continued for the next week." The event did not require hospitalization. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. This follow-up submitted to notify the batch/lot number not available despite the follow-up attempts made. Follow-up attempts completed. No further information expected.
I had normal side effects of arm pain (5 hours after vaccine),  tiredness (18 hours after vaccine), and  fever (18 hours after vaccine).  I took Ibuprofen for pain and fever 18 hours after vaccine, and experienced a bloody nose an hour after taking Ibuprofen, and again 3 hours after Ibuprofen.  Both bloody noses were short, lasting only 1-3 minutes each time.  However, I haven't had a bloody nose in decades, even after taking Ibuprofen.  I have not sought medical treatment yet.
After receiving the 3rd Booster of Pfizer 11/29/2021, patient started experiencing symptoms on 11/30/2021 of swelling and pain in the left lymph node. Experienced extreme fatigue lasting 24 hours (has since subsided). Primary communications 12/01/2021 (still waiting on recommendations).
Right ankle swollen; could not walk for several weeks; Leg cramp; pain in right leg that comes and goes; right leg swelled up; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (could not walk for several weeks), MUSCLE SPASMS (Leg cramp), PAIN IN EXTREMITY (pain in right leg that comes and goes) and PERIPHERAL SWELLING (right leg swelled up) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Fall from high place (fell off a roof 20 years ago), Coma (for 23 days after a fall), Clot blood (in left leg after being in coma for 23 days) and Nerve damage (left leg). Concurrent medical conditions included Depression (mild), Acid reflux (esophageal) and Disability. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), ST. JOHN'S WORT for Depression.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PERIPHERAL SWELLING (right leg swelled up) (seriousness criterion disability). On 26-Feb-2021 at 8:00 PM, the patient experienced MUSCLE SPASMS (Leg cramp) (seriousness criterion disability) and PAIN IN EXTREMITY (pain in right leg that comes and goes) (seriousness criterion disability). On 27-Feb-2021, the patient experienced GAIT INABILITY (could not walk for several weeks) (seriousness criterion disability). On 01-Apr-2021, the patient experienced JOINT SWELLING (Right ankle swollen). At the time of the report, GAIT INABILITY (could not walk for several weeks), MUSCLE SPASMS (Leg cramp) and PERIPHERAL SWELLING (right leg swelled up) outcome was unknown and PAIN IN EXTREMITY (pain in right leg that comes and goes) and JOINT SWELLING (Right ankle swollen) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, X-ray: normal (normal) no blood clots.         Treatment for the events included diclofenac sodium cream and paracetamol.  On 06 Mar 2021, a physician told the patient that it was okay for him to do  leg presses so he did 350 pounds x100 and he also walked in a pool.  He went home and after sitting for a half hour, his leg cramped up again and he needed a crutch to walk.  The patient also reported using a cane.  The patient stated, stated "now I just exercise leg with movements that seem to help."  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2021: City, state and zip code updated; patient's date of birth and race updated; medical history and concomitant medications added; events updated.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
4/9/21 2nd Moderna shot at 7 30ish am by 10 pm started to have a headache sever along with hit and cold chills, this lasted 2 days and the hat additional vomiting, muscle soreness all over body, muscle spaz . Headache pain was at 8 out of 10, body aches 6 out is ten. After a few days went to PCP for help. Did some blood work and scan on 4/15/21. Also referred to neurologist. After more scans and mri and LP ruled out neurology, was referred to rheumatologist more tests also in conclusive. Have not been able to work do to pain and headache. 2/23/22 went to the clinic and so Neurologistmore tests answer with NDPH and from rheumatology CSS as clinical diagnosis since there was nothing for reaction to vaccine.  As of Dec 15, 2022, still fighting sevre body pain, tingling and burning down arms and legs, brain fog, short term memory loss, waves of numbness in face nausea and  a 24/7 headache this all with that medicines  aren?t touching
This spontaneous report as received from a medical assistant/practice manager refers to multiple patients of unknown demographics. Reporter stated that improperly stored doses of RECOMBIVAX HB (lot # K021581, expiry date: 24-OCT-2016/Lot # M003658, expiry date: 02-JUN-2018) were administered to the patients on unspecified dates (incorrect product storage). No adverse effects were reported. The outcome was unknown. Temperature and time frame was 65F for 65 hours. Data logger was involved. There were no previous excursions. Back in range: Yes. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient experienced generalized hives. Patient went to the doctor's office on 04/02/2012 and was treated with prednisone. The symptoms lasted a couple of days after treatment. Patient recovered.
Problems started after high-dose flu shot Thurs 12-Oct.  Cold-like symptoms progressed from runny nose, exhaustion by Sunday to strangling cough, sore throat, unable to breathe--cough remained intermittent so could catch breath.  Took Covid self-test--negative.   Saw pri care doc Mon to confirm not Covid, not pneumonia.  Continued getting worse.  Was ready to go to Emergency Room due to inability to catch my breath. Beginning to feel better today Sun 21-Oct; shot was Thurs 12-Oct.  I know of another woman who was really sick for over one week.  I had the Pfizer Covid booster Thurs 5-Oct.
Immunocompromised patient received 50mcg booster dose instead of 100mcg full dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Immunocompromised patient received 50mcg booster dose instead of 100mcg full dose) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (Immunocompromised patient received 50mcg booster dose instead of 100mcg full dose). On 01-Dec-2021, ACCIDENTAL UNDERDOSE (Immunocompromised patient received 50mcg booster dose instead of 100mcg full dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Slight soreness on left arm. On 3/11/2021 I experienced extreme RIGHT arm pain - upper arm/elbow/to my hand. It was 95% gone on 3/12 and 99% gone on 3/13.
Pt received covid vaccine from us, shot went fine no issues.  Technician administered the shot.  About 5 minutes after pt became nauseous so I had her come into the health services room.  Handed her garbage can if she needed it to vomit in.  She ended up not needing it.  She stated that she felt clammy so I gave her a cold compress.  She used the compress.  I asked pt if she felt itchy (hives) and she said no.  I asked her if she had any unusual feeling in her heart beat and she said no.  A few minutes later pt said she wanted to lay down on floor, I accomodated that.  I asked pt throughout the process if she felt itchy (hives), or any other symptoms.  Pt continued to say that they felt a little better and nausea was subsiding.  Eventually pt's husband came and I let him into the room with the pt.  After about 5 more minutes pt said they felt better and the couple left together.  Pt thanked us for our assistance.
Headache; Muscle aches; Chills and shivers; This case was reported by a pharmacist via sales rep and described the occurrence of chills in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced chills, headache and muscle pain. On an unknown date, the outcome of the chills, headache and muscle pain were recovered/resolved.   It was unknown if the reporter considered the chills, headache and muscle pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported but patient was less than 60 years old at the time of reporting.  The patient received Shingrix and experienced chills and shivers lasting for 24 hours after the vaccine. Also experienced headache and muscle aches.
It was an immune response; Rashes all over body but more specifically on hands and feet; This spontaneous case was reported by an other health care professional and describes the occurrence of IMMUNISATION REACTION (It was an immune response) and RASH (Rashes all over body but more specifically on hands and feet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced IMMUNISATION REACTION (It was an immune response) and RASH (Rashes all over body but more specifically on hands and feet). At the time of the report, IMMUNISATION REACTION (It was an immune response) and RASH (Rashes all over body but more specifically on hands and feet) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.  Patient had emergency room visit and spoken to allergist. Allergist stated it was immune repose to something.   This case was linked to MOD-2021-417001 (Patient Link).
Body aches, worse than the first; Fatigue; Headache; Very sore arm; This case was reported by a nurse via sales rep and described the occurrence of general body pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (1st dose received on an unknown date, refer case US2022AMR060171).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced general body pain, fatigue, headache and pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the general body pain, fatigue, headache and pain in arm were unknown.   It was unknown if the reporter considered the general body pain, fatigue, headache and pain in arm to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR060171   Additional Information: GSK Receipt Date: 4-APR-2022 Reporter's Comment: The patient self-reported this case. The patient received dose Shingrix vaccine and experienced body aches, fatigue, headache, and a very sore arm. The patient thought this was the normal reaction though. The pharmacist warned her it would be worse than the first. The patient also stated that the second shot was wicked. The reporter consented to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR060171:Same reporter.
Systemic: see comments-Medium, Additional Details: pt was given expired vial of moderna vaccine. vial was punctured on may 30 2021 at 11am
02/10/2021, at 05:00 PM on the day of the vaccine, I started of with chill and fever, it got up to 101.9, I went to bed and throughout the night I was just shivering, at about 11:00 am the next day I turned the corner. All my symptoms subsided. I had a headache that lingered throughout the day and it went away the next day. My arm, I received the injection on, was hurting, it was red, swollen and itched and it didn't go away for a whole week. A week after the vaccine, 02/27/2021, I felt like I had bugs crawling all over me, on my forehead, head and all over my body and it lasted several days. I took Benadryl for like 3 days. Occasionally I fell like I still have bugs on me. The feeling has dissipated after several months, but occasionally I still feel like bugs are crawling on me, but it's not all the time. My asthma was exasperated by the vaccine within 24 hrs of taking it, but it subsided about a week.
Pt received Varivax vaccine on 01/19/2005 and was diagnosed with chicken pox on 09/08/2005. (mild case of Chicken Pox).
Morning of 2/19/10 area of injection was a little swollen. 4:30pm 2/19/10 area around injection swollen pt described as a 2 inch square lump. Hot to touch. No fever.
66 y.o. male patient with history of COPD and hypertension presented to hospital with acute respiratory failure with COVID-19 pneumonia   Covid-19 Viral Pneumonia Date of onset of symptoms: 12/22/2022 Symptoms present on admission: shortness of breath Date of covid positive test: 12/23/2022 Vaccination status: vaccinated but did not get 2022 booster Imaging: CXR with left lower lobe infiltrate Oxygen requirements on admission: BiPAP Current oxygen requirements: NC Medical therapy: steroids (continue 2 more days), rocephin, and zithromax (completed); started remdesivir 12/26 (completed)  Consultants following: Pulm Anticipated special isolation end date: 1/2/2023 Weaned down to 6L NC 12/29 -> weaned to 4 L NC prior to discharge, patient uses 3-6 L at home.  He has a pulse ox at home and was instructed to keep O2 sat greater than 88%.  He also has a CPAP machine that he uses at night.  He will need to follow up with his PCP and pulmonology    Acute on chronic hypoxic and hypercapnic respiratory failure Community acquired pneumonia Normally wears 3L O2 at home but occasionally bumps up O2 to 6L with activity, required BiPAP at 50% FiO2 on transfer VBG - pH 7.31, pCO2 77, pO2 58 CXR as above appears concerning for CAP in addition to COVID-19 PNA Azithromycin (completed 5 days) and Rocephin completed 7 days  Wean oxygen as tolerated Continue pulmonary toilet, showed patient how to use incentive spirometer  Pulmonology following   COPD exacerbation Increasing dyspnea, cough, and sputum production w/ color change Gold stage IV with FEV1 0.65 25% Treating above underlying causes Duonebs and inhalers ordered   Primary hypertension Continue lisinopril Restarting home amlodipine 12/29
Headaches, flushing of cheeks, had daily since getting vaccine. Has been taking Migraine Strength Excedrin. HX of migraines on Inderal. Last migraine 6-7 years ago. Gets headaches a lot before this but they were always relieved by